Griseofulvin-methisoprinol combination in the treatment of herpes zoster.
A total of 57 herpes zoster patients (28 men and 28 women) were randomly assigned to one of the following four treatments: griseofulvin, 125 mg four times daily; methisoprinol, 1 g four times daily; griseofulvin plus methisoprinol (dosage schedules as above); placebo, four times daily. Griseofulvin had no effect at all, methisoprinol both significantly accelerated drying of vesicles and reduced pain, and the combination of griseofulvin and methisoprinol turned out to be significantly more effective in reducing pain than methisoprinol alone. The present results suggest a new effective treatment for herpes zoster disease.
D000368:Aged; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006118:Griseofulvin / Q000008:administration & dosage / Q000627:therapeutic use*; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy
D006118:Griseofulvin; D007288:Inosine; D007542:Inosine Pranobex